resources

JFL Life Sciences Ltd.

NSE: JFLLIFE

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

11.15+0.3 (+2.29%)

24 Aug, 1:59 PM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

JFL Life Sciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2023	2024
Annual Reports	—	—
Quarterly Results	Mar Sept	Mar Sept
Conference Calls	—	—
Presentations	—	—

Corporate Announcements and Regulatory Filings

JFL Life Sciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Copy of Newspaper Publication12 Aug 2026
Jfl Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication
Outcome of Board Meeting10 Aug 2026
Jfl Life Sciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Copy of Newspaper Publication1 Aug 2026
Newspaper Publication of Notice for Shareholder s Meeting 25th august,2026
Shareholders meeting31 Jul 2026
Jfl Life Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 25, 2026
Certificate under SEBI (Depositories and Participants) Regulations, 20183 Jul 2026
Jfl Life Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for quarter ended June 30, 2026
Trading Window26 Jun 2026
Jfl Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Disclosure under SEBI Takeover Regulations5 Jun 2026
SMIRAL ASHWINKUMAR PATEL has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Copy of Newspaper Publication30 May 2026
Jfl Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication
Appointment29 May 2026
Jfl Life Sciences Limited has informed the Exchange regarding Appointment of JIGNESH as Other of the company w.e.f. May 29, 2026.
Updates29 May 2026
Jfl Life Sciences Limited has informed the Exchange regarding 'Reg.30'.
Outcome of Board Meeting29 May 2026
Jfl Life Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Structural Digital Database13 Apr 2026
STRUCTURED DIGITAL DATABASE COMPLIANCE CERTIFICATE FOR THE FINANCIAL YEARENDED MARCH 31, 2026
Certificate under SEBI (Depositories and Participants) Regulations, 20184 Apr 2026
Jfl Life Sciences Limited has informed the Exchange about Certificate for quarter ended March 31, 2026 under SEBI (Depositories and Participants) Regulations, 2018
Copy of Newspaper Publication25 Mar 2026
Jfl Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication w.r.t. under subscription of the Rights Issue
Trading Window25 Mar 2026
Jfl Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Outcome of Board Meeting24 Mar 2026
Jfl Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on March 24, 2026 that the Company has not achieved the minimum subscription requirement of 90% of the issue size, as prescribed under Regulation 86 (2) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, hence in this regards we are under process to give instruction to RTA i.e KFin Technologies Limited for Refund / unblock of amount lying under the ASBA Account who have applied for this Rights issue.
Updates4 Mar 2026
Jfl Life Sciences Limited has informed the Exchange regarding 'Outcome of Board Meeting held on Wednesday, March 04, 2026 to discuss matters pertaining to Rights Issue'.
Record Date4 Mar 2026
Jfl Life Sciences Limited has informed the Exchange that Record date for the purpose of Rights is 10-Mar-2026.
Rights Issue4 Mar 2026
Jfl Life Sciences Limited has informed the Exchange that Board of Directors at its meeting held on March 04, 2026, has decided to issue equity shares on rights basis in the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held. Issue Price is Rs. 10 per share.
Outcome of Board Meeting29 Jan 2026
Jfl Life Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

Frequently Asked Questions

Where can I download the annual report of JFL Life Sciences Ltd.?

Annual reports of JFL Life Sciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of JFL Life Sciences Ltd.?

Quarterly earnings results and presentations of JFL Life Sciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does JFL Life Sciences Ltd. publish earnings call transcripts?

Earnings call transcripts of JFL Life Sciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of JFL Life Sciences Ltd.?

Investor presentations and annual day presentations of JFL Life Sciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of JFL Life Sciences Ltd.?

Corporate announcements and regulatory filings of JFL Life Sciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of JFL Life Sciences Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of JFL Life Sciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of JFL Life Sciences Ltd.?

The ISIN (International Securities Identification Number) of JFL Life Sciences Ltd. is INE0LA901015. This is the unique identifier used across exchanges and depositories.

On which stock exchange is JFL Life Sciences Ltd. listed?

JFL Life Sciences Ltd. is listed on NSE and BSE. The NSE symbol is JFLLIFE and the BSE code is -.

Where can I find the shareholding pattern of JFL Life Sciences Ltd.?

The quarterly shareholding pattern of JFL Life Sciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for JFL Life Sciences Ltd. on Sharpely?

Share price data for JFL Life Sciences Ltd. is updated as of 24 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.